Massachusetts' Metabolix aims to price public offering of common stock

Deal has greenshoe of 712,500 shares; funds slated for working capital

By Devika Patel

Knoxville, Tenn., May 18 - Metabolix, Inc. will price a public sale of common stock, according to a prospectus supplement filed Wednesday with the Securities and Exchange Commission.

The company will sell 4.75 million common shares. The deal also has a greenshoe of 712,500 shares.

J.P. Morgan Securities LLC is the sole bookrunning manager, and Stifel Nicolaus Weisel is co-manager.

Proceeds will be used for working capital and other general corporate purposes.

Cambridge, Mass.-based Metabolix develops alternatives to petrochemical-based plastics, fuels and chemicals.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.